Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy
Condition(s):Hypertrophic CardiomyopathyLast Updated:May 26, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Hypertrophic CardiomyopathyLast Updated:May 26, 2020Completed
Condition(s):Left Ventricular Systolic Dysfunction; Sudden Cardiac DeathLast Updated:October 18, 2022Completed
Condition(s):Sudden Cardiac Death Due to Cardiac Arrhythmia; Cardiomyopathies; Ischemic Heart Disease; Cardiovascular DiseasesLast Updated:March 20, 2024Recruiting
Condition(s):Sudden Cardiac DeathLast Updated:February 6, 2023Not yet recruiting
Condition(s):Sudden Cardiac DeathLast Updated:March 17, 2021Completed
Condition(s):Sudden Cardiac DeathLast Updated:December 13, 2016Terminated
Condition(s):Sudden Cardiac Death; Myocardial InfarctionLast Updated:March 19, 2024Recruiting
Condition(s):Post Traumatic Stress Disorder; Resuscitated Sudden Cardiac DeathLast Updated:March 16, 2023Completed
Condition(s):Sudden Cardiac DeathLast Updated:April 2, 2018Unknown status
Condition(s):Death, Sudden, Cardiac; Ventricular Fibrillation; Ventricular Tachycardia; Congenital Heart DiseaseLast Updated:May 21, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.